methylprednisolone hemisuccinate has been researched along with Cytomegalovirus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Falagas, ME; Freeman, R; Griffith, J; Rohrer, R; Ruthazer, R; Snydman, DR; Werner, BG | 1 |
1 trial(s) available for methylprednisolone hemisuccinate and Cytomegalovirus
| Article | Year |
|---|---|
Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
Topics: Adolescent; Adult; Antilymphocyte Serum; Blood Transfusion; Boston; Child; Cytomegalovirus; Cytomegalovirus Infections; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Humans; Immunization, Passive; Immunoglobulins; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kidney; Liver; Liver Cirrhosis, Biliary; Liver Transplantation; Longitudinal Studies; Male; Methylprednisolone Hemisuccinate; Middle Aged; Multivariate Analysis; Placebos; Proportional Hazards Models; Survival Rate; Time Factors | 1997 |